Form 4 for RAPP Rapport Therapeutics, Inc.
Accepted 2025-09-10 00:00:00 ET · period of report 2025-09-08 · accession 0001839046-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-09-10 | 2025-09-08 | RAPP | Gault Cheryl | COO | M - OptEx | $1.80 | +5,000 | 176.9K | +3% | +$9,000 |
| DT | 2025-09-10 | 2025-09-08 | RAPP | Gault Cheryl | COO | S - Sale+OE | $38.33 | -5,000 | 171.9K | -3% | -$191.7K |
| DT | 2025-09-10 | 2025-09-08 | RAPP | Gault Cheryl | COO | M - OptEx | $0.00 | -5,000 | 110.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-08 | M | A | 5,000 | $1.80 | 176,928 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-08 | S | D | 5,000 | $38.33 | 171,928 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 5,000 | $0.00 | 110,407 | D | $1.80 · — to 2033-12-05 | 5,000 Common Stock | (F2) 25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |